Art. 88a Directive (EU) 2001/83

In forcesince 26 Jan 2007cited 11×

Within three years of the entry into force of Directive 2004/726/EC, the Commission shall, following consultations with patients' and consumers' organisations, doctors' and pharmacists' organisations, Member States and other interested parties, present to the European Parliament and the Council a report on current practice with regard to information provision — particularly on the Internet — and its risks and benefits for patients.

Following analysis of the above data, the Commission shall, if appropriate, put forward proposals setting out an information strategy to ensure good-quality, objective, reliable and non-promotional information on medicinal products and other treatments and shall address the question of the information source's liability.

The 10 that are cited most themselves, of 11.

  • Judgment of the Court (Third Chamber) of 1 October 2020. A v Daniel B and Others.Decision

    Title VIII, entitled ‘Advertising’, and Title VIIIa, entitled ‘Information and advertising’ of Directive 2001/83 contain, respectively, Articles 86 to 88 and Articles 88a to 100 of that directive.

    1 Oct 2020 · 62018CJ0649

  • Judgment of the Court (Third Chamber) of 11 June 2020. ratiopharm GmbH v Novartis Consumer Health GmbH.Decision

    Title VIIIa of Directive 2001/83, entitled ‘Information and Advertising’, comprises Articles 88a to 100 thereof.

    11 Jun 2020 · 62018CJ0786

  • Judgment of the Court (Fourth Chamber) of 22 April 2010. The Queen, on the application of Association of the British Pharmaceutical IndustryDecision

    Title VIII of the directive, entitled ‘Advertising’, contains Articles 86 to 88 thereof, whereas Title VIIIa of the directive, entitled ‘Information and advertising’, contains Articles 88a to 100.

    22 Apr 2010 · 62009CJ0062

  • Opinion of Mr Advocate General Ruiz-Jarabo Colomer delivered on 18 November 2008. Criminal proceedings against Frede Damgaard.Decision

    Directive 2001/83 was amended by Directive 2004/27/EC (8) because ‘the definitions and scope of Directive 2001/83/EC should be clarified in order to achieve high standards for the quality, safety and efficacy of medicinal products for …

    18 Nov 2008 · 62007CC0421

  • Judgment of the Court (Grand Chamber) of 22 December 2022. SIA 'EUROAPTIEKA' v Ministru kabinets.Decision

    Title VIII of that directive, entitled ‘Advertising’, and Title VIIIa thereof, entitled ‘Information and advertising’ contain, respectively, Articles 86 to 88 and Articles 88a to 100 of that directive.

    22 Dec 2022 · 62020CJ0530

  • Opinion of Advocate General Szpunar delivered on 9 June 2022. SIA 'EUROAPTIEKA' v Ministru kabinets.Decision

    It should be noted that, in the judgment in DocMorris, the Court held that an advertising campaign in the form of a prize competition allowing participants to win everyday items other than medicinal products, participation in that …

    9 Jun 2022 · 62020CC0530(01)

  • Opinion of Mr Advocate General Jääskinen delivered on 19 October 2010. Novo Nordisk AS v Ravimiamet.Decision

    Although the introduction of Article 88a and Title VIIIa have to a certain extent broken the cohesion of the scheme of the provisions on advertising in Directive 2001/83, I have no doubt that Articles 86 and 87 have general scope as …

    19 Oct 2010 · 62009CC0249

  • BGH, Beschluss vom 16. Juli 2009 - I ZR 223/06Decision

    … Diese Frage stellt sich nicht erst de lege ferenda (vgl. dazu Art. 88a der Richtlinie 2001/83/EG; Lorz, GRUR Int. 2005, 894, 897; Enderlein, BKK 2007, 457 ff.; Kiewel/Stuppardt, KrV 2008, 70 ff.; Rieß aaO S. 55 f.), sondern bereits de …

    16 Jul 2009 · I_ZR_223-06

  • Opinion of Advocate General Szpunar delivered on 24 October 2024. Apothekerkammer Nordrhein v DocMorris NV.Decision

    Title VIII, entitled ‘Advertising’, and Title VIIIa, entitled ‘Information and advertising’, of Directive 2001/83, contain, respectively, Articles 86 to 88 and Articles 88a to 100 of that directive.

    24 Oct 2024 · 62023CC0517

  • Opinion of Advocate General Trstenjak delivered on 24 November 2010. MSD Sharp & Dohme GmbH v Merckle GmbH.Decision

    However, at the same time, in Article 88a of Directive 2001/83 inserted later by Directive 2004/27, the European Union legislature stresses the need for ‘good-quality, objective, reliable and non-promotional information on medicinal …

    24 Nov 2010 · 62009CC0316